-Reuters
Anixa Biosciences’ COVID-19 Compounds Show Potential Efficacy Against Delta Variant
Anixa Biosciences Inc (NASDAQ:ANIX) has announced that a genomic variant analysis indicates that its potential compounds may be more effective…
Related Posts
Ericsson Enters $2B Sustainability-Linked Revolving Credit Facility
Telefonaktiebolaget L M Ericsson (NASDAQ:ERIC) inked a $2 billion sustainability-linked revolving credit facility, renewing an undrawn $2 billion credit facility signed in…
Duck Creek Technologies Q3 EPS $0.01 Down From $0.03 YoY, Sales $72.40M Beat $72.15M Estimate
Duck Creek Technologies (NASDAQ:DCT) reported quarterly earnings of $0.01 per share. This is a 66.67 percent decrease over earnings of $0.03 per share from the same period last year. The company reported quarterly sales
Telsey Advisory Group Maintains Outperform on Leslies, Lowers Price Target to $28
Telsey Advisory Group analyst Dana Telsey maintains Leslies (NASDAQ:LESL) with a Outperform and lowers the price target from $30 to $28.